Mr. Daniel Patrick

Daniel Patrick is a Finance Senior Fellow in the Department of Social Sciences at the United States Military Academy at West Point.

He is Executive Director, Portfolio Management, at Regeneron Pharmaceuticals, where he leads a group that integrates the entire development portfolio of post-research R&D assets through lifecycle management to enable efficient portfolio decision-making by executive leadership. He works with senior management across Research, Development, Manufacturing and Commercial to enable Portfolio Management excellence to drive pipeline delivery & portfolio value.

Prior to his work at Regeneron, Dan was Vice President, Corporate Portfolio Management, for HUTCHMED, a Hong Kong-based biopharmaceutical company. In this role, he was involved in a broad range of activities across the organization that drove the global pipeline, including drug project and portfolio investment decision operations, analytics, and portfolio performance management to enable decision-making for pipeline investments to expedite the delivery of new medicines to patients.

Dan has more than 30 years of professional experience in the Life Sciences and Financial Services industries. Dan’s career began at JP Morgan where he directly assisted industry analysts valuing companies in support of mergers & acquisitions transactions. He then joined Merck & Co. where he held positions of increasing responsibility in Finance, Operations, and R&D. In his last role at Merck, Dan led the R&D Division merger integration team for the Merck/Schering-Plough merger (deal value of $41 billion). He then joined Celgene Corporation as Executive Director of Global Financial Planning & Analysis. Following his tenure at Celgene, he became a Principal Consultant at TayganPoint Consulting Group, a boutique management consulting firm specializing in the life sciences industry, where he led project teams on critical client transformation projects and served as an adviser and thought leader for senior executives. He then led the Global R&D Business Operations and Analytics group at Daiichi Sankyo Co. for three years before his role at HUTCHMED.

Dan holds a BS in Finance from Manhattan College and an MBA in Finance & Marketing from the Simon Business School of the University of Rochester. He is also a certified Six Sigma Black Belt and has authored numerous articles on project management and R&D portfolio management.

Dan has lectured at USMA since 2008, primarily in SS394, SS494, SS463, and SS470. He has also been an adviser to the Investment Club and numerous Projects Day teams.